跳至主要内容
临床试验/NCT01827527
NCT01827527
已完成
不适用

Development and Validation of 31P Magnetic Resonance and Optical Spectroscopy for the Characterization of ATP in Whole Body Human Applications

AdventHealth Translational Research Institute1 个研究点 分布在 1 个国家目标入组 31 人2013年3月1日

概览

阶段
不适用
干预措施
Healthy Adult
疾病 / 适应症
Validation Studies
发起方
AdventHealth Translational Research Institute
入组人数
31
试验地点
1
主要终点
Rate of oxygen uptake
状态
已完成
最后更新
15天前

概览

简要总结

The purpose of this study is to develop and refine techniques for using magnetic resonance and optical spectroscopy to investigate how your body uses energy.

详细描述

Primary Study Objective: To evaluate the reproducibility of acquiring multi-nuclear data on a new 3T Philips Magnet in conjunction with Optical Spectroscopy.

注册库
clinicaltrials.gov
开始日期
2013年3月1日
结束日期
2024年12月30日
最后更新
15天前
研究类型
Observational
性别
All

研究者

发起方
AdventHealth Translational Research Institute
责任方
Sponsor

入排标准

入选标准

  • Male or female
  • Age 18 - 89
  • Healthy (self assessed)
  • Weight under 350lbs
  • Able to walk 50 yards without stopping
  • Able to travel to hospital for study visits
  • Able to follow a 3-step command
  • Able to remain in magnetic resonance (MR) scanner for up to 2 hours

排除标准

  • Have internal metal medical devices, including cardiac pacemakers, aortic or cerebral aneurysm clips, artificial heart valves, ferromagnetic implants, shrapnel, wire sutures, joint replacements, bone or joint pins/rods/screws, metal fragments in your eye, or non-removable jewelry such as rings.
  • Are unwilling or unable to complete the imaging procedures for the duration of the magnetic resonance imaging (MRI) scan due to claustrophobia or other reason.
  • Serious mental illness that might preclude subject's ability to comply with study treatment
  • Are pregnant or plan on becoming pregnant in the next 8 weeks.
  • History of deep vein thrombosis (DVT) or pulmonary embolism (PE)
  • Varicose Veins
  • Known genetic factor (Factor V Leiden, etc.) or hypercoagulable state, including cancer, leukemia - such as chronic myelocytic leukemia (CML), hemoglobinopathies - such as sickle-cell disease and multiple myeloma and other proteinopathies.
  • Diagnosed peripheral arterial or vascular disease
  • Family history of primary DVT or PE
  • Peripheral neuropathy

研究组 & 干预措施

Healthy Adult

This is a protocol development study, with no interventions or treatments.

结局指标

主要结局

Rate of oxygen uptake

时间窗: Hour 2

OS will be used to measure the oxygen (O2) uptake by following the rate of Hb-O2 and Mb-O2 deoxygenation during ischemia. The rate of the depletion of these O2 stores measures the rate of O2 uptake by the mitochondria. The Horbia Jobin Yvon optical system will be used. The OS acquisition procedure has been thoroughly described by Marcinek et.al

Rate of phosphocreatine (PCr) decay

时间窗: Hour 2

The PCr decay (rate of PCr breakdown during ischemia) will be used to measure the ATP turnover rates (ATPase). After the baseline is established, the volunteer will be asked to perform contractions of the quadriceps (by slight kicking) for up to 45 seconds. . After kicking is stopped, the volunteer will remain still for an additional 5 minutes in order to allow the PCr peak to return to baseline. The ATPase experiment will also be performed by acquiring 31P Spectra every 6 seconds.

研究点 (1)

Loading locations...

相似试验